Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Optibrium Limited, a provider of software and artificial intelligence (AI) solutions for drug discovery, announced the publication of a peer-reviewed study in Applied AI letters “Deep Imputation on Large-Scale Drug Discovery Data”.
read more
Optibrium announced the introduction of its Augmented Chemistry™ services, which provide collaborators with novel artificial intelligence technologies to supplement their skills and experience, enabling them to make more effective decisions and ...
read more
Tuesday, January 17, 2023
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the appointment of Steve Yemm as Chief Commercial Officer (CCO), the latest in a series of senior-level hires as the Company rapidly expands.
read more
Optibrium Ltd and BioPharmics LLC, leading providers of software and computational solutions for drug discovery, announce their partnership. Industry-leading 3D ligand-based design approaches from BioPharmics will be available in Optibrium’s small ...
read more
Thursday, August 31, 2023
Optibrium, a developer of software and AI solutions for drug discovery, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology, ...
read more
OpSec Security has announced a COVID-19 testing kit authentication and traceability solution.
read more
Wednesday, October 31, 2012
Overcoming the challenges of conducting China’s largest outcomes trial and how it relates to doing business in this vital emerging market will be the topic of a joint presentation by Anja Moellman, Senior Project Director for Theorem Clinical ...
read more
Wednesday, February 01, 2017
OPKO Health has announced that its subsidiary and business unit, GeneDx, is entering into a collaboration with the Deciphering Developmental Disorder (DDD) study led by the Wellcome Trust Sanger Institute.
read more
OPKO Health has announced the appointment of Gregory Henderson, M.D., Ph.D., as President of Bio-Reference Laboratories (BRL), effective immediately.
read more
Tuesday, September 27, 2016
OPKO Health, Inc. has announced the appointment of Benjamin D. Solomon, M.D. as Managing Director of GeneDx, effective as of October 3, 2016. GeneDx, part of OPKO’s BioReference Laboratories subsidiary, specializes in genetic testing for rare ...
read more
Monday, September 10, 2018
Opiant and Consort announced a development and manufacturing agreement for Opiant’s OPNT003, a potent, long-acting opioid antagonist for the treatment of opioid overdose.
read more
The Wasdell Group announced its new state-of-the-art facility in Dundalk, Ireland has received its MIA from the Health Products Regulatory Authority (HPRA).
read more
The Open Serialization Communication Standard (Open-SCS) Group, a collection of healthcare sector companies dedicated to standardizing packaging line serialization and aggregation data exchanges, is making steady progress in its goal of drafting a ...
read more
Wednesday, September 02, 2020
Open Book Extracts (OBX) is voluntarily recalling to the consumer level all lots of Always Be Clean Hand Sanitizer and Just Hand Sanitizer that are labeled to contain methanol.
read more
Monday, November 23, 2020
Onyx Scientific announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
read more